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PENGENALPASTIAN DAN PENCIRIAN PENANDA PROTEIN DAN 
PEMBANGUNAN IMUNOASAI UNTUK PENGESANAN PENYAKIT 
SISTA HIDATID 
 
ABSTRAK 
 
Penyakit sista hidatid (HCD) atau hidatidosis adalah disebabkan jangkitan 
oleh larva Echinococcus granulosus. Ia boleh mengancam manusia dan banyak 
haiwan lain termasuklah hidupan liar serta ternakan komersil. Antigen daripada 
parasit yang mendorong tindakbalas humoral dan imun sel perumah berpotensi 
untuk bertindak sebagai penanda dalam pengesanan awal HCD.  Pengesanan HCD 
adalah berdasarkan tanda klinikal dan kaedah pengimejan, tetapi ianya tidak 
spesifik. Kaedah pengimejan tidak dapat membezakan antara sista hidatid dan lesi 
lain, dengan itu imunodiagnosis digunakan sebagai kaedah diagnosis tambahan 
dalam pengesanan penyakit ini. Pada ketika ini, tiada ujian piawai dengan 
sensitiviti dan spesifisiti yang tinggi bagi imunodiagnosis HCD. Menerusi kajian 
ini, antigen daripada parasit telah disediakan daripada protoskoleks E. granulosus 
dan cecair sista hidatid (HCF) daripada sista hidatid yang diperoleh daripadai biri-
biri yang dijangkiti secara semulajadi. Sampel serum diperolehi daripada 130 
orang pesakit HCD, 38 individu yang dijangkiti dengan jangkitan parasit lain serta 
30 individu sihat. Konjugat peroksida (HRP) IgG dan IgG4 telah digunakan 
sebagai antibodi sekunder. Gel elektroforesis dua dimensi dan blot Western/dot 
telah digunakan untuk mengenal pasti jalur protein protoskoleks dan HCF yang 
menunjukkan sensitiviti dan spesifisiti diagnostik yang baik. 
Satu antigen protoskoleks pada jalur 60 kDa didapati mempunyai 82% 
(40/49) sensitiviti diagnostik dan 100% (68/68) spesifisiti diagnostik untuk 
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pengesanan HCD, apabila diuji dengan IgG4-HRP anti-manusia. Manakala 33%  
(10/30) sensitiviti dan 100% (68/68) spesifisiti diperolehi apabila diuji dengan 
IgG-HRP anti-manusia. Menerusi analisis jisim spektrometri menerusi MALDI 
TOF/TOF, jalur ini telah dikenal pasti sebagai tegumen protoskoleks paramiosin. 
Protein rekombinan daripada jujukan penuh paramiosin telah dihasilkan; dan 
sensitiviti dan spesifisiti diagnostik dalam  blot IgG4 masing-masing adalah  86% 
(42/49) dan 98% (58/59). 
Dua jalur antigenik daripada HCF telah dikenalpasti iaitu 8 kDa dan 37 
kDa, dan masing-masing menunjukkan 86% (42/49) and 67% (33/49) sensitiviti 
diagnostik; dan 100% (67/67) and 98% (66/67) spesifisiti diagnostik apabila diuji 
dengan IgG4-HRP anti-manusia. Dengan IgG-HRP anti-manusia, sensitiviti dan 
spesifisiti bagi jalur antigen 8 kDa masing-masing adalah 88% (43/49) dan 37% 
(10/27).  Jisim spektrometri dengan MALDI TOF/TOF telah mengenalpasti jalur 8 
kDa sebagai AgB/1, manakala jalur 37 kDa pula dikenalpasti sebagai Ag5. 
Berdasarkan kepada jujukan AgB/1, peptida yang mempunyai 54 residu dengan 
berat molekul 6.415 kDa telah disintesis. Dengan menggunakan dot blot, peptida 
sintetik pRZ telah menunjukkan 90% (18/20) sensitiviti diagnostik dan 40% (8/20) 
spesifisiti diagnostik apabila diuji dengan IgG-HRP anti-manusia. Apabila diuji 
dengan IgG4-HRP anti-manusia, sensitiviti diagnostik ialah 88% (43/49) dan 
spesifisiti diagnostik ialah 100% (42/42). Kad membran nitroselulosa telah 
digariskan dengan pRZ yang berkepekatan pada 0.75, 1, 1.25, 1.5 dan 2 mg/ml, 
dan dipotong menjadi dipstik berdasarkan teknologi „lateral flow‟.  Dipstik pada 
dua kepekatan terakhir (1.5 dan 2 mg/ml) menunjukkan sensitiviti dan spesifisiti 
diagnostik yang tinggi, masing-masing adalah 98% (41/42) dan 100% (85/85). 
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Secara kesimpulannya, pengesanan IgG4 daripada dua protein sista hidatid 
iaitu paramiosin daripada protoskoleks dan AgB/1 daripada HCF didapati berkesan 
sebagai penanda diagnostik bagi HCD. Rekombinan paramiosin dan peptida 
sintetik AgB/1 pRZ menunjukkan nilai diagnostik yang baik.  Kajian ini telah 
berjaya menghasilkan ujian pantas dipstik menggunakan pRZ, yang berasaskan 
pengesanan antibodi IgG4 dan teknologi „lateral flow‟. Ia menunjukkan potensi 
yang baik bagi pengesanan HCD secara pantas dan tepat dan sangat berguna di 
kawasan endemik HCD yang amnya kurang membangun.  
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IDENTIFICATION AND CHARACTERIZATION OF PROTEIN 
MARKERS AND DEVELOPMENT OF IMMUNOASSAY FOR 
DETECTION OF HYDATID CYST DISEASE 
 
ABSTRACT 
 
Hydatid cyst disease (HCD) or hydatidosis is caused by an infection with 
the larval stage of Echinococcus granulosus. It affects human and animals, 
including wildlife and commercial livestock. The parasite antigens induce host 
humoral and cellular immune responses which may serve as potential markers in 
early detection of HCD. Diagnosis of HCD is based on non-specific clinical signs 
and imaging of suspected organs such as liver and lungs. Imaging methods cannot 
differentiate between hydatid cysts and other lesions such as liver abscess and 
neoplasms, therefore, immunodiagnosis is an important additional tool to detect 
the infection. Currently, there is no standardized test with high sensitivity and 
specificity that is available for the immunodiagnosis of HCD. In this study parasite 
antigens were prepared from E. granulosus protoscolex and hydatid cyst fluid 
(HCF) of hydatid cysts from naturally infected sheep. Serum samples were 
obtained from 130 HCD patients, 38 individuals infected with other parasitic 
infections and 30 healthy people. Peroxidase (HRP)-conjugated anti-human IgG 
and IgG4 were used as secondary antibodies. Two-dimensional gel electrophoresis 
and western/dot blot were used to identify protein bands of protoscolex and HCF 
that exhibited good diagnostic sensitivity and specificity.  
A protoscolex antigenic band of 60 kDa was found to be 82% (40/49) 
sensitive and 100% (68/68) specific for detection of HCD when probed with anti-
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human IgG4-HRP. Meanwhile the diagnostic sensitivity and specificity were 33% 
(10/30) and 100% (68/68) respectively when probed with anti-human IgG-HRP. 
By mass spectrometry analysis using MALDI TOF-TOF, the band was identified 
as protoscolex tegument paramyosin. The full length recombinant form of the 
paramyosin protein was produced; and the diagnostic sensitivity and specificity in 
IgG4 blots were found to be 86% (42/49) and 98% (58/59) respectively. 
Two antigenic bands from hydatid cyst fluid (HCF) were identified namely 
8 kDa and 37 kDa;  the diagnostic sensitivities were found to be 86% (42/49) and 
67% (33/49) respectively; while the diagnostic specificities were determined to be 
100% (67/67) and 98% (66/67) respectively when probed with anti-human IgG4-
HRP. When analysed using anti-human IgG-HRP, the sensitivity and specificity of 
the 8kDa antigenic band was 88% (43/49) and 37% (10/27), respectively. By mass 
spectrometry using MALDI TOF-TOF, the 8kDa band was identified as AgB/1 
and the 37 kDa band as Ag5. Based on the AgB sequence identified in this study, a 
peptide of 54 residues with molecular weight of 6415 Da was selected and custom-
synthesized. Using dot blot, the synthetic peptide (pRZ) showed diagnostic 
sensitivity of 90% (18/20) and specificity of 40% (8/20) when probed with anti-
human IgG-HRP; and sensitivity of 88% (43/49) and a specificity of 100% 
(42/42), when probed with anti-human IgG4-HRP. Nitrocellulose membrane cards 
were separately lined with the pRZ at 0.75, 1, 1.25, 1.5 and 2 mg/ml and cut into 
lateral flow dipstick strips. The dipsticks using the last two concentrations showed 
high diagnostic sensitivity of 95% (40/42) and 98% (41/42) respectively, and 
specificity of 100% (85/85).  
In conclusion, IgG4 detection of two hydatid cyst protein markers i.e. 
paramyosin from protoscolex and AgB/1 from HCF, were found to be useful for 
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the diagnosis of HCD. The recombinant form of paramyosin and the synthetic 
peptide of AgB/1 (pRZ) showed good diagnostic value. This study has 
successfully produced a rapid dipstick test using pRZ based on IgG4 detection and 
lateral flow technology. The test shows high potential for rapid, accurate diagnosis 
of HCD and would be useful in low resource settings of HCD endemic areas. 
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CHAPTER ONE 
INTRODUCTION 
 
1.1      Overview of Hydatid Cyst Disease  
            Hydatid cyst disease (HCD), also called cystic echinococcosis (CE), cystic 
hydatid disease (CHD), or unilocular echinococcosis, is caused by the larval stage 
(metacestode) of the tapeworm Echinococcus granulosus in human, wild life and 
livestock. Dogs and other canids harbour the adult worms in their small intestine 
and serve as the definitive host. Humans as intermediate host acquire the disease 
by accidental ingestion of vegetables or water contaminated with ova of adult 
worms excreted by canids. After exposure to the gastrointestinal enzymes, the 
infective ovum hatches into oncosphere which reaches organs such as liver and 
lungs through the vascular and lymphatic systems. The larva then develops into 
hydatid cyst, which is gradually filled with fluid and protoscoleces. The disease is 
chronic, complex, and neglected (Brunetti et al., 2011). It results in considerable 
loss of disability adjusted life years (DALYs) in many under developed parts of the 
world and is not easy to diagnose because of the chronic course of the disease and 
lack of proper diagnostic facilities.  
Recently, the World Health Organization (WHO) included HCD in a 
separate group known as “neglected zoonotic diseases” i.e. diseases which have 
not been given enough importance at national or international levels (WHO, 2010; 
Giri and Parija, 2012). HCD not only causes severe illness, but also causes 
economic losses due to costs related to diagnosis and surgery. This disease is 
scattered throughout the world with an emerging or re-emerging status in several 
countries. Re-emerging status with remarkable economic loss has also been 
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reported from developed countries (Rojo-Vazquez et al., 2011). Early diagnosis is 
based on clinical signs, which is followed by imaging of suspected organs. Clinical 
signs in humans are not specific and the imaging methods cannot differentiate 
between hydatid cysts, tumours and other lesions (Hira et al., 1993; Babba et al., 
1994; Metanat et al., 2008). Therefore, immunodiagnosis remains an important 
additional tool in the primary diagnosis of the disease and for follow-up of patients 
after surgical or pharmacological treatment (Ortona et al., 2003a). Chordi and 
Kagan (1965) first used immunoelectrophoresis on sheep hydatid cyst fluid and 
identified antigenic components that were reactive with antibody in serum samples 
of patients with hydatid cyst. A successful immunodiagnostic test depends on the 
use of highly specific and sensitive antigen(s), as well as the detection of the 
appropriate antibody class or subclass. Detection of circulating antigens in serum 
was reported to be less sensitive than detection of Echinococcus-specific 
antibodies (Zhang et al., 2003).  
 
1.2    History of HCD 
HCD has been well known to human since ancient times. Francisco Redi in 
the 17th century recognised the parasitic nature of hydatid cyst and Pallas showed 
that the cyst was the larval stage of tapeworms. In 1801, the term„echinococcus‟ 
was coined by Rudolphi. Siebold showed the life cycle by feeding dogs with 
Echinococcus cysts from sheep, and in 1863 Naunyn demonstrated this by feeding 
dog with human Echinococcus cysts (Cox, 2002). In the 19th century, physicians 
recognized the disease and in the 20
th
 century significant progress in the field of 
diagnosis and treatment, epidemiology, immunology and molecular medicine were 
achieved (Eckert, 2007). In Iran, E. granulosus was reported in stray dogs in 
3 
 
Tehran by Makarehchian and Janbakhsh in 1956 (Ghafarifar, 2010) and in 1971 
Mobedi and Sadighian reported Echinococcus multilocularis for the first time in 
three of 30 red foxes from northwest Ardebil province in Iran (Mobedi and 
Sadighian, 1971).  
 
1.3      Classification of Echinococcus 
Echinococcus is a multicellular organism and belongs to the Kingdom 
Animalia, and Phylum Platyhelminthes. This parasite is in Class Cestoda 
(tapeworm) because of its ribbon-shaped segmented body, lack of gut and outer 
body covered by syncytial tegument with microtriches. It is classified under 
subclass Eucestoda due to it being a hermaphrodite and contains calcareous 
corpuscles. All tapeworms of humans are in the Order Cyclophyllidea because of 
the existence of two hosts within its life cycle and presence of scolex with four 
suckers. Non-operculated eggs, genitalia unpaired in each proglottid with marginal 
genital pore placed this parasite in the family of Taeniidae. However, it is 
substantially different from other members of this family for having no more than 
six segments as so compared to the species of Taenia which has several thousand 
segments (Thompson and McManus, 2001). 
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The full classification of the genus Echinococcus is as follows: 
Kingdom      Animalia  
Phylum         Platyhelminthes 
Class             Cestoda 
Subclass        Eucestoda 
Order             Cyclophyllidea     
 Family          Taeniidae 
 Genus           Echinococcus (Rudolphi, 1801) 
 
Species:      granulosus (Batsch, 1786) 
                    multilocularis (Leuckart, 1863)  
                    oligarthrus (Diesing, 1863)  
                    vogeli (Rausch and Bernstein, 1972) 
                    shiquicus (Xiao et al., 2005) 
 
                  canadensis )Thompson, 2008) 
 
 
  E. granulosus which causes HCD and E. multilocularis which causes 
alveolar hydatid disease are the most important species due their ability to cause 
severe disease and economic loss. Two other species, E. vogeli and E. oligarthrus, 
are the causative agents of polycystic echinococcosis in central and south America 
and only a few cases have been reported in man (D‟Alesandro, 1997; Eckert and 
Deplazes, 2004). E. shiquicus was reported only in small mammals from Tibetan 
plateau (Xiao et al., 2005), and E. canadensis involves wolves and large cervids in 
North America and Scandinavia (Thompson, 2008).  E. granulosus is divided into 
10 strains, i.e. G1- G10 and this is elaborated in section 1.10 of this thesis. 
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1.4       Morphology and biology of E. granulosus 
1.4.1    Adult worm     
E. granulosus is one of the smallest tapeworms and measures 
approximately 3.0-8.5 mm in length (Figure 1.1). It is composed of scolex, neck 
and strobila. Scolex or head is round in shape and consists of 4 muscular suckers 
and a rostellum with 28–40 hooks in 2 circular rows. Large hooks measure 30–40 
μm in length and the short ones are 22–34 μm; the neck which is a regenerative 
region is short. Just behind the neck, the strobila or body consists of 3 to 5 
proglottids.  
The first or first two proglottids are immature and contain no genital 
organs; the last but one is mature. The mature segment contains both male and 
female organs. The male organ consists of 45 to 60 follicular testes. The vas 
efferens originate from each testis which united to build the single duct vas 
deferens. Vas deferens leads into the cirrus which is the male copulatory organ 
(Roberts and Janovy, 2009). The female organs consist of an ovary linked into a 
collecting tubule. Oviduct which ends in a coiled blind-ending uterus and the duct 
which runs into the vagina are located in the cirrus pouch and opens to the lateral 
genital pore. Adult worm is hermaphroditic and capable of self-semination.  
The last proglottid is gravid; it is longer than broad and measures 2.0 mm × 
0.5–1.0 mm. The uterus is fully filled with about 5000 eggs. The eggs are ovoid, 
30–37 μm in diameter and contain a hexacanth oncosphere; and by light 
microscopy it cannot be differentiated from those of Taenia species found in dogs 
(Thompson and McManus, 2001; Muller and Wakelin, 2002). The eggs are 
presumed to be fully embryonated and infective when released from the definitive 
host.  
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Figure 1.1 E. granulosus adult worm 
 
A: Diagram of an E. granulosus adult worm showing the structures of the major 
organs (source: http://www.clem.Mscd.edu).  
 
B: Light microscopy of E. granulosus adult worm stained with carmine (x100) 
(source: http:// www.herramientas.educa.madrid.org). 
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Food exchanges take place through the microtriches of the syncytial outer 
covering (the tegument) due to the lack of the digestive system. The adult worm 
has five pairs of longitudinal nerves. The motor nerve endings help to contract the 
suckers to assist in adherence (Flisser and Craig, 2005). Flame cells are 
constitutive of the osmoregulatory-excretory system of adult worm that feed 
ventrolateral and dorsolateral canals. These excretory canals start on each side 
along the strobila and a transverse canal joins them at the posterior margin of each 
proglottid (Roberts and Janovy, 2009). 
Adult E. granulosus have been found in various carnivores such as stray 
and farm dogs, red foxes, golden jackals and wolves (Rokni, 2008). They are 
infected by ingestion of viscera of dead intermediate hosts containing fertile 
hydatid cysts (cyst with viable protoscoleces). After ingestion, protoscolex is 
invaginated into the posterior region until external factors which include the 
microtopography of the intestine, biochemical and immunological factors of the 
host
'
s bile stimulate it to evaginate. At this stage, the apical region of the scolex 
evaginates and the organism penetrates deeply between the villi into the crypts of 
Lieberkuhn in the host‟s proximal small bowel, where it develops into adult stage 
in 32 to 80 days. Sexual maturity starts with unordered excretion of eggs and 
discharging of gravid proglottids on the surface of faeces. The definitive hosts 
harbour the adult worms in their intestine (Rogan and Richards, 1987; Lewall, 
1998). 
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1.4.2    Larval stage or metacestode (hydatid cyst) 
The larval stage of E.granulosus in intermediate hosts develops into a 
unilocular fluid-filled cyst which causes HCD in the human. Hydatid cysts vary in 
size from 1-20 cm in diameter (Eckert and Deplazes, 2004) (Figures1.2 and 1.3).  
The cyst consists of three layers i.e. outer pericyst or fibrous layer, ectocyst or 
laminated layer, and endocyst or germinal layer (Mohan, 2013) (Figure 1.4). 
 
1.4.2.1 Pericyst (Fibrous layer) 
Pericyst is an adventitial layer consisting of collagen and fibroblast tissue 
produced by the host tissue to surround the cyst. The cyst receives nutrients 
through blood vessels of pericyst by diffusion (von Sinner and Lewall., 2001). 
 
1.4.2.2 Ectocyst (Laminated layer) 
 Laminated layer is a polysaccharide protein complex composed of mucins 
bearing defined galactose rich carbohydrates, and is accompanied by calcium 
inositol hexakisphosphate deposits secreted by the germinal layer (Diaz et al., 
2011b; Diaz et al., 2011a). This acellular, hyaline laminated layer is about 1 mm 
thick that forms around the germinal layer between 2 and 4 weeks post-infection in 
the intermediate host after ingestion of the egg and release of the oncosphere 
(Zhang et al., 2003). The process by which nutritive substances are absorbed takes 
place in this layer. This is not a flexible layer and stains strongly by Periodic Acid-
Schiff (PAS) stain )Gottstein and Reichen, 2009). 
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Figure 1.2 Sheep liver hydatid cyst (source: Department of Parasitology; School 
of Medical Sciences, Tarbiat Modares University, Tehran, Iran) 
 
 
 
Figure 1.3 E. granulosus unilocular cyst gross specimen (source:http//www.Phs 
source.us/PH/PARA/Chapter 8.htm) 
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Figure 1.4 Diagram of a section through part of a unilocular hydatid cyst (source:  
http://www. rowdy.msudenver.edu/). 
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1.4.2.3 Endocyst (germinal layer)  
The endocyst or cellular germinal layer with 10–25 μm thickness is the true 
wall of the cyst. The structure of the germinal layer shows characteristics that 
partially resembles the tegument of adult worm. It is composed of syncytial 
cytoplasm through which the microtriches enters the upper acellular cell. Germinal 
layer facilitates cyst proliferation and reproduction and produces brood capsules 
and scoleces as well as laminated layer (Galindo et al, 2008).  
 
1.4.2.4 Brood capsule 
Brood capsules as shown in Figure 1.4 are small vesicles (Moro and 
Schantz, 2009) or small secondary cysts which bud internally from the germinal 
layer and produce multiple protoscoleces by asexual reproduction (Siracusano et 
al., 2009). Small vesicles or daughter vesicles are attached by a stalk to the 
germinal layer of the mother cyst and create a scene of a bunch of grapes. These 
vesicles may grow through the wall of the mother cyst and produce the daughter 
cyst or rupture and release the protoscoleces in the hydatid fluid (Garcia, 2007). 
 
1.4.2.5 Protoscolex 
Protoscoleces emerge from the inner wall of the brood capsule which in 
turn emerge from the germinal layer. A protoscolex measures about 140 × 80 μm 
(Cheesbrough, 2004). Protoscolex looks like the adult scolex with presence of 
rostellum containing double row of hooklets at the apical part. The hooks of the 
upper row with mean length of 25.9-35.0 μm contain rounded robust guards that 
are larger than the hooks of the lower row (22.6-27.8 μm) which have flattened 
guards (Antoniou and Tslentis, 1993). After ingestion by a definitive host, the 
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apical region of the scolex (namely suckers, rostellum and hooklets) evaginates 
and the organism then attaches to the gut wall and grows into an adult worm. 
However, if the hydatid cyst ruptures and releases protoscoleces with invaginated 
heads into the surrounding tissue, they may differentiate into new hydatid cysts 
(Figure 1.5). The whole protoscoleces and other components such as brood 
capsules, hooks and calcareous corpuscles suspended in a hydatid cyst fluid and 
form white sediment at the bottom of the cyst are called hydatid sand (John and 
Petri, 2006; Czermak et al., 2008). A human hydatid cyst usually contains 500 ml 
fluid floating hydatid sand with about 400,000 protoscoleces per ml. 
 
1.4.2.6 Calcareous corpuscles 
A major component of E. granulosus protoscoleces is calcareous 
corpuscles which are differentiated parenchymal cells, spherical or ovoid in shape 
and have a diameter ranging between 2-16 µm. They correspond to about 14% of 
the protoscoleces dried weight (McManus and Bryant, 1995) and contain organic 
base of DNA, RNA, proteins and inorganic ions (Mehlhorn, 2008). Calcium 
carbonate is the major component of E. granulosus calcareous corpuscles; in 
addition magnesium and phosphates are also present (Smith and Richards, 1993). 
The function of calcareous corpuscles is not completely clear. A hypothesis 
suggested that their phosphate could serve as a source of energy for metabolic 
requirements and carbonate content function as a buffering system. Disappearance 
of calcareous corpuscles in the initial establishment and development process of 
protoscolex to adult worm in the definitive host supports the above hypothesis 
(Rodrigues et al., 1997). 
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Figure 1.5 Diagram of protoscolex of E. granulosus. (A) An invaginated scolex 
(B) An evaginated scolex (source: Tropical Medicine Central Resource 
http://www.isradiology. org (C) E. granulosus protoscolex stained with eosin 
(x100) (source: http://www. medicine. cmu. ac.th). 
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1.4.2.7 Hydatid Cyst Fluid (HCF) 
HCF is a colourless fluid with pH 6.7 and specific gravity of 1 to 1.010   
and is produced by the germinal layer. It contains sodium chloride, sodium 
sulphate and salts of succinic acid (Parija, 2004).  Biochemical analysis of HCF 
showed presence of glucose, calcium, creatinine, uric acids, urea, bilirubin, 
alkaline phosphatase, glycogen, phospholipids, cholesterol and triglycerides 
(Vatankhah et al., 2003; Radfar and Iranyar, 2004).  A pressure of up to 300 mm 
of water keeps the endocyst in intimate contact with the pericyst (Palmer and 
Reeder, 2000).  
 
1.5  Life Cycle of E. granulosus 
The life cycle of E. granulosus requires two mammalian hosts (Figure 1.6). 
A definitive host is one in which the adult develops (in the small intestine) and the 
sexual phase completes; and an intermediate host in which the metacestode stage 
and protoscoleces usually develop (in the viscera) and the asexual phase occurs. In 
the natural cycle (also called the domestic cycle), the definitive hosts are dogs and 
other carnivores and the intermediate host are herbivores such as sheep, cattle, 
camel and pig. In the sylvatic cycle, the definitive and intermediate hosts are 
wolves and cervids respectively. The adult worm excretes eggs or gravid 
proglottids containing eggs along with faeces and contaminates the environment. 
As an intermediate host, humans acquire the disease by accidental ingestion of 
vegetables or water contaminated with the eggs of adult worm. Infective ovum 
hatches in the human duodenum; the oncosphere is released from the keratinized 
embryophore, probably after being activated by bile salts. The released 
oncosphere, possibly by secretions or using the hooklets, penetrates the small 
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intestinal mucosa and reach the internal organs through the vascular and lymphatic 
systems. The larva then develops into a hydatid cyst and is gradually fully filled 
with fluid and protoscoleces. Most (>90%) hydatid cysts occur in liver, lung, or 
both organs (Brunetti et al., 2011), and rarely in other organs like bones, brain, 
kidney (Etaiwi and Mabreh, 2008; Metanat et al., 2008; Mongha et al., 2008; 
Csotye et al., 2011; Rabbani et al., 2011; Vural et al., 2011). Hydatid cyst 
measures about 1 mm in diameter after 1 month and 10–55 mm after 5 months. 
When infected viscera of sheep or other livestock containing cysts and viable 
protoscoleces are ingested by dogs, protoscoleces evaginate in the stomach and are 
released in the small intestine. They attach to the intestinal wall through the action 
of the four suckers and double row of hooks, and mature into adult worms within 
6-7 weeks. 
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Figure 1.6 Life cycle of E. granulosus (source: http://www.dpd.cdc.gov/dpdx). 
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1.6   Brief immunology of HCD 
Three significant features of E. granulosus infection are the fact that 
different mammalian species act as intermediate hosts; long-term growth of the 
hydatid cysts in internal organs and location of the unilocular cysts in different 
organs, mainly liver and lungs of humans (Zhang et al., 2012). Chemale et al. 
(2003), Monteiro et al. (2010) and Aziz et al. (2011) have demonstrated the 
similarity between the complement of host proteins found in the HCF and host 
plasma. This sugests that E. granulosus is capable of adsorbing host proteins as 
nutrients across its outer germinal layer or to overcome host defences either by 
antigen disguise or by inhibition of effectors of host immunity (Schroeder et al., 
2009). Host age, sex, and physiological state of the intermediate host are three 
factors which may influence the innate susceptibility or resistance to infection with 
E. granulosus. 
Human hydatid cysts are described as fertile, sterile and calcified. The 
protoscoleces are in the fertile cysts, but a proportion of cysts does not produce 
protoscoleces and are sterile (Salem et al., 2011). It is noticeable that hydatid cysts 
are generally fertile in sheep and sterile in cattle (Zhang et al., 2003; Daryani et al., 
2009). Some cysts die due to hypermaturation followed by starvation and become 
a mummified, inert calcified cyst. Dead cysts show calcified cyst wall which can 
occur at any stage of the cysts life cycle (Lewall, 1998; Czermak et al., 2008). 
 
1.6.1  Host immune response in pre-encystment phase 
 After the oncosphere locates an internal organ and develops into primary 
hydatid cyst, it is confronted by the host humoral and cellular immune responses to 
the parasite (Al-Sakee, 2011). Cell-mediated responses involve infiltration of 
18 
 
macrophages, eosinophils, neutrophils and fibrocytes and low-level polarized Th1 
responses. Antibody responses to HCF and oncospheral antigens are low in the 
early infection (Zhang et al., 2003). A possible role for antibody-dependent cell 
mediated cytotoxicity (ADCC) reaction is the killing of E. granulosus oncospheres 
by neutrophils in association with antibodies (Rogan et al., 1992).  
 
1.6.2  Host immune response in post-encystment phase 
Parasite produces antigens that modulate the immune responses. Th1 
cytokines produce IL-2, IFN- gamma and lymphotoxin, whereas Th2 cytokines 
express IL-4, IL-5, IL-6 and IL-10. Th1 and Th2 are cross-inhibitory and also they 
down-regulate each other (Tamarozzi et al., 2010). Antigen B family of E. 
granulosus which is implicated in Th2 induction is reported to inhibit neutrophil 
migration (Siracusano et al., 2008a; Siracusano et al., 2008b). Thus, Th2 responses 
are directly related to susceptibility to the parasitic infection, while Th1 responses 
are correlated with protective immunity (Ortona et al., 2003b; Amri et al., 2009). 
IFN- gamma inhibits Th2-cell proliferation, whereas IL-10 inhibits the synthesis of 
Th1 cytokines. They are at high levels in hydatid infection and may be due to the 
complex antigens in HCF. When a cyst dies naturally, or is killed under 
pharmacological treatment with albendazole or mebendazole or is removed by 
surgery, Th2 responses drop rapidly and Th1 responses become dominant 
suggesting that Th1 responses have a role in the process of cyst degeneration. 
When a cyst relapses and becomes active, the Th2 responses regenerate very 
quickly and IL-5 and IL-6 are produced in large quantities. IL-5 regulation is 
associated with the regulation of specific IgE and IgG4 and regulates eosinophilic 
response. In HCD patients, there is a correlation between production of IL-4 and 
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IL-10, and IgE and IgG4; therefore, both IL-4 and IFN-gamma regulate the IgE 
and IgG4 responses. IL-6 induces differentiation of B cells into plasma cells, 
therefore contributing to the development of antigen-specific humoral responses. 
In addition, IgG, especially IgG1 and IgG4, IgE and IgM are predominant as the 
cyst grows and becomes established whereas the concentrations of specific IgG1 
and IgG4 decline in patients with cyst infiltration or calcification (Zhang et al., 
2003; Zhang et al., 2006; Zhang et al., 2012).   
 
1.7  E. granulosus antigens 
E. granulosus produces different antigens during its various developmental 
stages which modulate the host immune response and also promote parasite 
survival and development. These antigens are those of HCF antigens, protoscolex 
and adult somatic antigens and oncosphere antigens (Hewitson et al. 2009; Fotoohi 
et al., 2013). 
 
1.7.1  HCF antigens 
Two major HCF antigens, antigens B and 5 are lipoproteins. Both have 
been well characterized by immunoblotting, immunoprecipitation of radiolabeled 
antigen and sodium-dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-
PAGE) (Shepherd and McManus, 1987). Both antigens are located in the 
interstitial material between the parenchymal cells and associated with the 
disorganized areas in the connective area of the germinal membrane and in the 
parenchyma of the protoscoleces. The brood capsule wall and the brood capsule 
contents, the protoscoleces tegument, the parenchymal cells, the muscle cells, the 
calcareous corpuscles and the hooks do not contain antigen 5 or antigen B 
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(Sanchez et al., 1993). These antigens can be found and measured in the patients 
blood as circulating antigens (Liu et al, 1993). According to Oriol et al. (1971), by 
precipitation at low ionic strength (0.005 M acetate buffer, pH 5), purified HCF 
fraction can be obtained from crude sheep hydatid fluid. 
Antigen B and 5 are not specific for E. granulosus as patients with 
infections of E. multilocularis, E. vogeli also have detectable levels of specific 
antibody to these antigens in their serum samples (Lightowlers et al., 1989). 
 
1.7.1.1 Antigen B 
Antigen B (AgB), the largest component of the HCF with a molecular mass 
of 120-160 kDa, is a polymeric thermostable lipoprotein (Oriol and Oriol., 1975) 
which can withstand temperatures up to 100°C for 15 min without losing 
antigenicity (McVie et al., 1997). It dissociates into three main subunits at 8/12, 16 
and 20 kDa in SDS-PAGE under reducing and non-reducing conditions. The 
previous findings suggest that 8 kDa subunit is the smallest compartment of AgB 
which contains at least two components (Gonzalez et al., 1996), namely AgB8/1 
(Frosch et al., 1994) and Ag B8/2 (Mamuti et al., 2006; Mamuti et al., 2007). 
These components may constitute the building blocks of higher molecular weight 
subunits. Rott et al. (2000) evaluated the recombinant antigens EgAgB8/1 and 
EgAgB8/2 in ELISA and found that the latter was more effective than rEgAgB8/1 
or native AgB for diagnosis of human HCD. Virginio et al. (2003) evaluated these 
two recombinant antigens in total IgG-ELISA. They showed that rEgAgB8/2 
presented higher sensitivity and specificity than rEgAgB8/1. On the other hand, 
another study reported that rEgAgB8/1 performed better at detecting all subclasses, 
particularly IgG4 than rEgAgB8/2; and N-terminal extension of the AgB8/1 
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subunit (p176), provided a better diagnostic performance than native AgB 
(Gonza´lez-Sapienza et al., 2000). 
The 8/12 kDa subunit is the most important subunit in diagnostic studies 
and induces good humoral and cellular responses (Siracusano et al., 2008b). AgB 
as a protease inhibitor, inhibits neutrophil recruitment (Shepherd et al., 1991) and 
exploits the activation of T-helper cells by eliciting a non-protective Th2 cell 
response. Recently, findings showed that AgB induces apoptosis in 
polymorphonuclear cells from patients with active disease (Rigano et al., 2002). 
Until now, using phylogenetic tools there is no data on how many genes are 
represented in the AgB family, although it is known that AgB is encoded by a 
multigene family having at least five gene sites (B1–B5), each gene consisting of 
several minor variants that are grouped into two clusters i.e. EgAgB1/B3/B5 and 
EgAgB2/B4 (Frosch et al., 1994). These five AgB genes differ in amino acid 
sequences (44–81%). Recently, it was shown that the AgB family comprises at 
least 10 genes in five subclasses which are differentially expressed. AgB1, AgB2, 
AgB3 and AgB4 genes are expressed in Echinococcus metacestodes; while AgB5 
transcripts were detected at very low levels in the larval stage, increasing its 
expression in the adult worm, which suggests an adult-specific function (Zhang et 
al., 2010). The parasite uses the mechanism of switching among these variants to 
evade the host immune response (Haag et al., 2004). AgB is homologous to, and 
shares structural similarities with helix-rich hydrophobic ligand binding proteins 
(HLBPs) from other cestodes and exhibits fatty acid binding properties (Chemale 
et al., 2005). There were reported sero-reactivities between the smallest subunit of 
AgB and antibodies in serum samples from alveolar hydatid disease and Taenia 
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solium cysticercosis patients (Lightowlers et al., 1989; Leggatt and McManus 
1994). 
 
1.7.1.2 Antigen 5 
 
Antigen 5 (Ag5) with a molecular mass of 400 kDa is a polypeptide chain 
thermolabile lipoprotein detected by a precipitation line (arc 5) in 
immunoelectrophoresis assays (Carmena et al., 2006). It dissociates into subunits 
at 55 and 65 kDa in SDS-PAGE under non reducing conditions. 
Under reducing conditions, it dissociates into two subunits at 38/39 and 
22–24 kDa linked by disulphide bond (Di Felice et al., 1986). Processing of the N-
terminal region of the original polypeptide chain generates the 22 kDa subunit 
whereas the 38 kDa component relates to the C-terminal portion (Lorenzo et al., 
2003). The existence of a single amino acid sequence with alternative residues at 
some positions of the 38 kDa subunit N-terminal fraction and presentation of Ag5 
in different isoforms proposes the hypothesis that Ag5 is similar to AgB and may 
be encoded by a multigene family which are variably expressed (Zhang et al., 
2003). There is reported cross-reactivities between Ag5 and antibodies in serum of 
patients with alveolar hydatid disease, T. solium cysticercosis and other helminth 
infections due to the presence of phosphorylcholine bound to the 38 kDa subunit 
(Shepherd and McManus, 1987). The sites of heparan sulphate proteoglycans and 
calcium-binding in the 22 kDa subunit provide binding targets for the Ag5 
molecule (Lorenzo et al., 2003) and ensure its foci in the host tissue surrounding 
the metacestode (Siracusano et al.,  2011). 
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1.7.1.3 Other antigens of HCF 
1.7.1.3.1 E. granulosus thioredoxin peroxidase (EgTPx) 
Antioxidant protein thioredoxin peroxidase was identified by screening 
an E. granulosus cDNA library with IgG1 from patients with HCD (Margutti el 
al., 2008). It is one of the important protoscolex excretory–secretory proteins 
localized in tegument, subtegument and calcareous corpuscle cells of the 
protoscolex. EgTPx is secreted into HCF and seems to intervene in evasion 
mechanisms adopted by the parasite to establish infection by inducing a strong 
humoral response in patients with HCD (Virginio et al., 2012). This protein plays 
the role of enzymatic scavenger of hydrogen peroxide in E. granulosus (Li et al., 
2004a; Li et al., 2004b). 
 
1.7.1.3.2 E. granulosus tegumental antigen (EgTeg) 
 EgTeg is a tegumental protein located in the tegument of protoscolex, on 
the germinal layer of the cyst wall and in the HCF. It is an immunomodulatory 
molecule which induces a strong humoral response in patients with chronic HCD. 
EgTeg significantly inhibits polymorphonuclear cell chemotaxis, induce IL4 
positive T lymphocytes and non-complement fixing antibodies (IgG4). The 
hypothesis of the role of EgTeg in excitation of the host immune response is due to 
an unclear mechanism of secretion or release of EgTeg during the degeneration of 
the protoscoleces into the HCF (Ortona et al., 2005). 
 
1.7.1.3.3 E. granulosus A31 (EgA31) 
EgA31 is a fibrillar protein of approximately 66 kDa with some properties 
of paramyosin. It is localized in the tegument of the adult and on the surface of the 
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protoscolex body wall; and presents in the subtegumental parenchyma, a region 
rich in muscle at both adult and protoscoleces stages. It is also present in the 
germinal layer of the cyst. There is not a large amount of EgA31 protein in the 
sucker regions at the time of invagination of protoscoleces in the intermediate host. 
The highest concentration of EgA31 is observed in the adult at the region of the 
suckers after the head evaginates, this suggests that EgA31 protein may be 
involved in the immune escape mechanisms (Fu et al., 1999). 
 
1.7.1.3.4  Cyclophilin (EA21) 
E. granulosus cyclophilin was identified both in protoscoleces and in HCF. 
Cyclophilin is an allergenic molecule that is specifically recognized by IgE from 
patients with HCD. It is involved in the allergic reactions manifested by the 
patients and does not cross-react with cyclophilins from other organisms (Ortona et 
al., 2002; Siracusano et al., 2008a; Siracusano et al., 2008b). 
 
1.7.1.3.5 E. granulosus alkaline phosphatase (EgALP) 
E. granulosus ALP is present in the germinal layer surface of the hydatid 
cyst (del Cacho et al., 1996) and is also a component of the HCF. Its activity in 
fertile HCF is significantly more than in sterile HCF (Vatankhah et al., 2003). 
 
1.7.1.3.6 Heat shock proteins (HSPs) 
HSPs have immunostimulatory properties and their levels increase in 
organisms which are exposed to conditions of stress such as heat or chemicals. The 
protoscoleces express several members of HSP i.e. HSP70, HSP60, HSP40 and 
HSP20. HSP70 has been identified as an antigen in E. granulosus human infection. 
